The group
Five companies. Complementary expertise.
Firalis Group brings together five companies with complementary expertise and services. From biomarker discovery and clinical research to bioproduction, diagnostics, digital pathology and micropollutant analysis, each company contributes its own capabilities to the Group.
Looking for a specific service?
Explore our services to find the expertise you need and the Firalis Group company behind it.
- FiralisCardiovascular biomarker discovery, bioproduction, biobanking and clinical trials, with CE and FDA regulatory support.
- AmonetaInnovative biomarkers for the diagnosis of neurological disease.
- IVDiasContract development and manufacturing for RUO and in vitro diagnostics assays.
- BioCellviaIntelligent, quantitative image analysis for histopathology.
- LodiagDetection and quantification of micropollutants in complex matrices.